GeneOne Life Science, Inc. (KRX:011000)
2,120.00
+20.00 (0.95%)
At close: Nov 5, 2025
GeneOne Life Science Revenue
GeneOne Life Science had revenue of 6.81B KRW in the quarter ending June 30, 2025, a decrease of -26.67%. This brings the company's revenue in the last twelve months to 34.71B, down -14.92% year-over-year. In the year 2024, GeneOne Life Science had annual revenue of 35.72B, down -11.15%.
Revenue (ttm)
34.71B
Revenue Growth
-14.92%
P/S Ratio
5.19
Revenue / Employee
846.70M
Employees
41
Market Cap
180.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 35.72B | -4.48B | -11.15% |
| Dec 31, 2023 | 40.20B | -8.52B | -17.48% |
| Dec 31, 2022 | 48.72B | 10.02B | 25.89% |
| Dec 31, 2021 | 38.70B | -2.80B | -6.75% |
| Dec 31, 2020 | 41.50B | 261.48M | 0.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.03T |
| Celltrion | 3.75T |
| Yuhan | 2.17T |
| Hanmi Pharm. | 1.47T |
| SK Biopharmaceuticals | 620.28B |
| PharmaResearch | 449.81B |
| Sam Chun Dang Pharm. | 215.10B |
| ALTEOGEN | 158.06B |